COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 972: Articles 9711-9720  | Next

Despite the odds: formation of the SARS-CoV-2 methylation complex.
Matsuda, A., Plewka, J., Chykunova, Y., Jones, A. N., Pachota, M., Rawski, M., Mourao, A., Karim, A., Kresik, L., Lis, K., Minia, I., Hartman, K., Sonani, R., Schlauderer, F., Dubin, G., Sattler, M., Suder, P., Popowicz, G., Pyrc, K., Czarna, A.
10.1101/2022.01.25.477673 — Posted: 2022-01-26
Biodistribution and Environmental Safety of a Live-attenuated YF17D-vectored SARS-CoV-2 Vaccine Candidate
Li, L.-H., Liesenborghs, L., Wang, L., Lox, M., Yakass, M. B., Jansen, S., Rosales Rosas, A. L., Zhang, X., Thibaut, H. J., Teuwen, D., Neyts, J., Delang, L., Dallmeier, K.
10.1101/2022.01.24.477505 — Posted: 2022-01-26
Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine
Wu, Y., Wang, S., Zhang, Y., Yuan, L., Zheng, Q., Wei, M., Shi, Y., Wang, Z., Ma, J., Wang, K., Nie, M., Xiao, J., Huang, Z., Chen, P., Guo, H., Lan, M., Xu, J., Hou, W., Hong, Y., Chen, D., Sun, H., Xiong, H., Zhou, M., Liu, C., Guo, W., Guo, H., Gao, J., Li, Z., Zhang, H., Wang, X., Li, S., Cheng, T., Zhao, Q., Chen, Y., Wu, T., Zhang, T., Zhang, J., Cao, H., Zhu, H., Yuan, Q., Guan, Y., Xia, N.
10.1101/2022.01.25.477789 — Posted: 2022-01-26
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
Shi, W., Wang, L., Zhou, T., Sastry, M., Yang, E. S., Zhang, Y., Chen, M., Chen, X., Choe, M., Creanga, A., Leung, K., Olia, A. S., Pegu, A., Rawi, R., Shen, C.-H., Stancofski, E.-S. D., Talana, C. A., Teng, I.-T., Wang, S., Corbett, K. S., Tsybovsky, Y., Mascola, J. R., Kwong, P. D.
10.1101/2022.01.25.477770 — Posted: 2022-01-26
Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)
Vanhove, B., Marot, S. S., Evanno, G., Mallet, I., Rouvray, G., Shneiker, F., Mevel, E., Ciron, C., Rousse, J., Royer, P.-J., Lheriteau, E., Raffi, F., Duvaux, O., Marcelin, A.-G., Calvez, V.
10.1101/2022.01.26.477856 — Posted: 2022-01-26
Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
Unoh, Y., Uehara, S., Nakahara, K., Nobori, H., Yamatsu, Y., Yamamoto, S., Maruyama, Y., Taoda, Y., Kasamatsu, K., Suto, T., Kouki, K., Nakahashi, A., Kawashima, S., Sanaki, T., Toba, S., Uemura, K., Mizutare, T., Ando, S., Sasaki, M., Orba, Y., Sawa, H., Sato, A., Sato, T., Kato, T., Tachibana, Y.
10.1101/2022.01.26.477782 — Posted: 2022-01-26
Cytotoxic T lymphocytes targeting a conserved SARS-CoV-2 spike epitope are efficient serial killers
Fathi, M., Charley, L., Cooper, L. J. N., Varadarajan, N., Meyer, D.
10.1101/2022.01.24.477535 — Posted: 2022-01-26
Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses
Mao, T., Goldman-Israelow, B., Suberi, A., Zhou, L., reschke, m., pena-hernandez, M., Dong, H., Homer, R., Saltzman, M., Iwasaki, A.
10.1101/2022.01.24.477597 — Posted: 2022-01-26
Adverse events following COVISHIELD (ChAdOx1nCoV-19) vaccination among health care workers in Sri Lanka; a multi-centre cross sectional survey
Manilgama, S. R., Hettiarachchi, N. M., Jayasinghe, I. K., De Silva, S. T., Jayalath, T., Wanigaratne, T., Rathnayake, B. P., Suganthan, N., Sudarshan, P., Pathirage, M., Rajaratnam, N., Senaratne, G., Rajapaksha, V., Wickramasinghe, A., Ranaweera, S. P. A. L., Thilakarathna, A. H. M., Kulaweera, M. T. D.
10.1101/2022.01.26.22269788 — Posted: 2022-01-26
Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysis
Spensley, K., Gleeson, S., Martin, P., Thomson, T., Clarke, C. L., Pickard, G., Thomas, D. C., McAdoo, S. P., Randell, P., Kelleher, P., Bedi, R., Lightstone, L., Prendecki, M., Willicombe, M.
10.1101/2022.01.25.22269804 — Posted: 2022-01-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).